4
Changes in Ownership
ClearPoint Neuro, Inc. Filed Acc 0001193125-26-011866
CEO and President sold 20,000 shares at $16.12 ($322,400)
- CEO and President acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BURNETT JOSEPH · CEO and President
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $2.50 | $50,000 | 31,565 | D |
| 2026-01-09 | Sale : show line 2 in the form 10b5-1 | −20,000 | $16.12 | $322,400 | 11,565 | D |
| Open-market sales · 20,000 sh · avg $16.12 · $322,400 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-09 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Options (right to buy) | −20,000 | 330,000 | D |
Loading xslF345X05/ownership.xml…